| ²é¿´: 86 | »Ø¸´: 2 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
gaoshandian1½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
Ãû´Ê5
|
||
|
Multimeric protein (¶àÑÇ»ùµ°°×ÖÊ)£ºÓÉÒ»¸öÒÔÉÏÑÇ»ù×é³ÉµÄµ°°×ÖÊ¡£ Mutagens (ÓÕ±ä¼Á)£ºÍ¨¹ýÓÕµ¼DNA ÉϵÄÍ»±äÔö¼ÓÍ»±äÂʵÄÎïÖÊ¡£ Mutation (Í»±ä)£ºÖ¸»ùÒò×éDNA ÐòÁÐÉϵÄÈκθı䡣 Mutation frequency (Í»±äƵÂÊ)£ºÔÚÖÖȺÖÐij¸öÍ»±ä±»·¢ÏֵįµÂÊ¡£ Mutation rate (Í»±äÂÊ)£ºÄ³¸öÍ»±ä·¢ÉúµÄËÙÂÊ£¬Í¨³£ÓÃÿ¸ö»ùÒòÿ´ú³öÏֵĴÎÊý±íʾ¡£ Myeloma (¹ÇËèÁöϸ°û)£ºÆðÔ´ÁÜÓÚ°Íϸ°ûµÄÒ»¸öÖ×Áöϸ°ûÖ꣬ͨ³£²úÉúÒ»ÖÖÃâÒßÇòµ°°×ÖÊ¡£ N Negative complementation (¸º»¥²¹)£ºµ±µÈλ»ùÒò¼ä»¥²¹ÔÊÐí¶àÑÇ»ùµ°°×ÖÊÖÐÍ»±äÑÇ»ùÒÖÖÆ Ò°ÉúÐÍÑÇ»ùµÄ»îÐÔʱ·¢Éú¡£ Negative regulators (¸ºµ÷¿ØÎï)£ºÍ¨¹ý¹Ø±Õת¼»òÕß·ÒëÀ´ÐÐʹ¹¦ÄÜ¡£ Negative supercoiling (¸º³¬ÂÝÐý)£ºË«Á´DNAÔÚ¿Õ¼äÒÔË«ÂÝÐýÁ´Ðýת·½ÏòÏà·´µÄ·½ÏòÐÎ³É µÄŤÇú¡£ Neutral substitution (ÖÐÐÔÖû»)£ºµ°°×ÖÊÖв»¸Ä±ä»îÐÔ°±»ùËáµÄ±ä»¯¡£ Nick (ÇпÚ)£ºÖ¸Ë«Á´DNA ÖÐÒ»ÌõÁ´ÉÏÁ½¸öÏàÁÚºËÜÕËá¼äȱÉÙÁ×Ëá¶þÖ¬¼ü¡£ Nick *** (ÇÐ¿ÚÆ½ÒÆ)£ºÖ¸´ó³¦¸Ë¾úÖÐDNA¾ÛºÏøIÄܹ»½«ÇпÚ×÷Ϊһ¸öÆðµã£¬½«Ë« Á´DNAÖеÄÒ»ÌõÁ´·Ö½â²¢ÓÃÐÂÎïÖÊÖØÐºϳÉÐÂÁ´´úÖ® ¡£¿ÉÓÃÀ´ÔÚÌåÍâÏòDNAÄÚÒý Èë·ÅÉäÐÔ±ê¼ÇºËÜÕËá¡£ Noautonomous controlling elements (·Ç×ÔÖ÷³É·Ö)£ºÓÐȱÏݵÄת×ù×Ó£¬Ö»ÓÐÔÚͬÀàÐÍ×ÔÖ÷³É ·Ö°ïÖúϲÅÄÜת×ù¡£ Nondisjunction (²»·ÖÀë)£ºÖ¸È¾É«µ¥Ìå(˫ȾɫÌå)ÔÚ¼õÊý·ÖÁÑ»òÓÐË¿·ÖÁÑÖв»ÄÜÏòÁ½¼«Òƶ¯¡£ Nonpermissive conditions (·ÇÐí¿ÉÌõ¼þ)£º²»ÔÊÐíÌõ¼þÖÂËÀÍ»±ä´æ»î¡£ Nonrepetitive DNA (·ÇÖØ¸´DNA)£º±íÏÖ³öÓëµ¥¸öÐòÁÐÒ»ÑùµÄ¸´ÐÔ¶¯Á¦Ñ§ÌØÕ÷µÄDNA¡£ Nonreplicative transposition (·Ç¸´ÖÆÐÍת×ù)£ºÖ¸×ª×ù×Ó½«¹©Ì岿λÐòÁÐÖ±½ÓÒÆµ½ÐµÄλµã (ͨ³£²úÉúÒ»¸öË«Á´¶Ï¿Ú)¡£ Nonsense codon (ÎÞÒåÃÜÂë×Ó)£ºUAG¡¢UAA¡¢UGA)ÖеÄÈκÎÒ»¸ö£¬ÒýÆðµ°°×ÖʺϳÉÖÕÖ¹(UAG ±»³ÆÎªçúçêÃÜÂë×Ó£¬UAA ±»³ÆÎªô÷ʯÃÜÂë×Ó)¡£ Nonsense mutation (ÎÞÒåÍ»±ä)£ºÖ¸DNAÉÏÈκδú±í°±»ùËáµÄÃÜÂë×Ó±äΪÖÕÖ¹ÃÜÂëµÄÍ»±ä¡£ Nonsense suppresser (ÎÞÒåÒÖÖÆ)£º±àÂëÄÜʶ±ðÒ»¸ö»ò¶à¸öÖÕÖ¹ÃÜÂë×ÓµÄÍ»±ätRNA »ùÒò¡£ Nontranscribed spacer (·Çת¼¼äÇø)£º»ùÒò×éÖÐǰºóת¼µ¥Î»Ö®¼äµÄÇøÓò¡£ Northern blotting (NorthernÔÓ½»)£º½«ÇíÖ¬ÌÇÄý½ºÉϵÄRNA×ªÒÆµ½ÏõËáÏËάĤÉÏ´Ó¶øÄܹ»Óë »¥²¹DNA ÔÓ½»µÄ¼¼Êõ¡£ Nuclear envelope (ºËĤ)£ºÎ§Èƺ˵ÄÒ»²ã˫Ĥ½á¹¹£¬ÆäÉÏÓк˿ס£ÄÚĤÔÚÄÚ²¿ÓëºË²ãÕ³Á¬µ° °×½áºÏ¡£ÍâĤÔÚϸ°ûÖÊÖÐÑÓÉìµ½ÄÚÖÊÍøµÄ¹Ç¼Ü¡£ Nuclear lamina (ºËÏ˲ã)£ºÔÚºËĤÄÚÓÉÈýÖÖÒÔÉϺËÕ³Á¬µ°°×Öʹ¹³ÉµÄµ°°×Öʲ㡣 Nuclear matrix (ºË»ùÖÊ)£ºÎ§Èƺʹ©Í¸ºËµÄ¹Ç¼Ü¡£ Nuclear pores (ºË¿×)£ºÔÚºËĤÉÏÑÓÉìµÄ´ó¿××´½á¹¹£¬¿ÉÔËÊä´ó·Ö×Ó½ø³öºË¡£ Nucleoid (ÀàºË)£ºÏ¸¾úÖаüº¬»ùÒò×éµÄ½ô´Õ½á¹¹¡£ Nucleolar organizer (ºËÈÊ×éÖ¯Çø)£ºÐ¯´ø±àÂërRNA »ùÒòµÄȾɫÌåÇøÓò¡£ Nucleolus (ºËÈÊ)£ºÓÉÓÚrRNA »ùÒòµÄת¼¶øÐγɵĺËÄÚ½ô´ÕÇøÓò¡£ Nucleolytic reaction (Èܺ˷´Ó¦)£ºÉæ¼°µ½ºËËáÖÐÁ×Ëá¶þÖ¬¼üµÄË®½â¡£ Nucleosome (ºËСÌå)£ºÈ¾É«ÖʵĻù±¾½á¹¹Ñǵ¥Î»£¬ÓÉ200bp DNAºÍ×éµ°°×Öʰ˾ÛÌå×é³É¡£ Null mutation (¿Õ°×Í»±ä)£ºÄܹ»ÍêÈ«Ïû³ý»ùÒò¹¦ÄÜ£¬Í¨³£ÊÇÓÉÓÚ»ùÒòµÄÎïÀíɾ³ýµ¼Ö¡£ O Ochre codon (ô÷ʯÃÜÂë×Ó)£ºUAA£¬ÊÇÒýÆðµ°°×ÖʺϳÉÖÕÖ¹µÄÈý¸öÃÜÂë×ÓÖ®Ò»¡£ Ochre mutation(ô÷ʯͻ±ä)£ºÈκβúÉúUAA µÄDNA Í»±ä¡£ Ochre suppressor(ô÷ʯÐÍÒÖÖÆ×Ó)£º±àÂëÄÜʶ±ðUAA ÃÜÂë×Ó´Ó¶øÊ¹µ°°×ÖʺϳɼÌÐøµÄÍ»±ä tRNA »ùÒò¡£¸ÃÍ»±ä×ÓÒ²ÄÜÒÖÖÆçúçêÍ»±ä¡£ Okazaki fragment (¸ÚÆéƬ¶Î)£ºÔÚ·ÇÁ¬Ðø¸´ÖÆÖвúÉúµÄ1000£2000bp ¶ÌƬ¶Î£¬Ëæºó±»Á¬½Ó ³ÉÍêÕûµÄ¹²¼ÛÁ´¡£ Oncogenes (°©»ùÒò)£ºÆä»ùÒò²úÎï¾ßÓÐת»¯ÕæºËϸ°ûµÄÄÜÁ¦£¬Ê¹Ö®ÓëÖ×Áöϸ°ûÏàͬµÄ·½Ê½Éú ³¤¡£Äæ×ªÂ¼²¡¶¾Ð¯´øµÄ°©»ùÒòͨ³£v-onc±íʾ¡£ Open reading frame (ORF£¬¿ª·Å¶ÁÂë¿ò)£º²»º¬ÖÕÖ¹ÃÜÂë×Ó¡¢ÓɱàÂë°±»ùËáµÄÈýÁªÌå×é³ÉµÄ Á¬ÐøDNA ÐòÁУ¬ÄÜ·Òë³Éµ°°×ÖÊ¡£ Operator(²Ù×Ý»ùÒò)£ºDNA ÉϵÄÒ»¸öλµã£¬×è¶ôµ°°×ÄÜÓëÖ®½áºÏÒÖÖÆÏàÁÚÆô¶¯×Ó´Ó¶øÒÖÖÆ ת¼¡£ Operon (²Ù×Ý×Ó)£ºÏ¸¾ú»ùÒò±í´ïºÍµ÷¿ØµÄµ¥Î»£¬°üÀ¨½á¹¹»ùÒòºÍÄܱ»µ÷¿Ø»ùÒò²úÎïʶ±ðµÄ DNA ¿ØÖÆÔª¼þ¡£ Organelles(ϸ°ûÆ÷)£ºÏ¸°ûÖÊÖеĽṹµ¥Ôª£¬±»Ä¤Ëù°üΧ¡£ Origin(Ե㣬Ori)£º¸´ÖÆÆðʼ´¦µÄDNA ÐòÁС£ Orphans(¹Â¶À»ùÒò)£ºÔÚ¶ÀÁ¢Î»µãÉÏ·¢Ïֵĵ¥¸ö»ùÒò£¬µ«ËüÓëÒ»¸ö»ùÒò´ØÏà¹Ø¡£ Overwinding of DNA(DNA ¹ýÐý)£ºÑØË«Á´ÖÐÁ½ÌõÁ´µÄ²øÈÆ·½Ïòʹ֮¸ü½ôµÄÕý³¬ÂÝÐý¡£ P Packing ratio (°ü×°±È)£ºÖ¸DNA ³¤¶ÈÓëÆä°üº¬ÏËάµ¥Î»³¤¶ÈµÄ±ÈÖµ¡£ Pairing of chromosomes (ȾɫÌåÅä¶Ô)£º¼ûÁª»áȾɫÌå¡£ Palindrome (»ØÎÄÐòÁÐ)£ºDNAÐòÁÐÖÐÒ»ÌõÁ´´Ó×óµ½ÓÒÔĶÁºÍÁíÒ»ÌõÁ´´ÓÓÒµ½×ó¶ÁÊÇÒ»ÑùµÄ ÐòÁУ¬ÓÉÏàÁڵķ´ÏòÖØ¸´×é³É¡£ Papovaviruses (ÈéÍ·¶àÁö²¡¶¾)£ºÊÇÒ»Àà»ùÒò×é½ÏСµÄ¶¯Îﲡ¶¾£¬°üÀ¨SV40 ºÍ¶àÁö²¡¶¾¡£ Paranemic joint (ƽÐлã½Ó)£ºÖ¸Á½¸öDNA»¥²¹ÐòÁм粢¼çÁ¬½ÓÔÚÒ»Æð¶ø²»ÊÇÒÔË«ÂÝÐý½á¹¹ ²øÈÆÔÚÒ»ÆðµÄÇøÓò¡£ pBR322£ºÒ»¸ö±ê×¼µÄÖÊÁ£¿ËÂ¡ÔØÌå¡£ PCR(¾ÛºÏøÁ´Ê½·´Ó¦)£ºÖ¸Í¨¹ý±äÐÔÓëÒýÎïÍË»ð£¬ÔÚDNA¾ÛºÏø×÷ÓÃÏÂʹDNAÑÓÉìµÄÑ »·¼¼Êõ£¬Äܽ«Ä¿±êDNA ÐòÁÐÊýÁ¿À©Ôöµ½106±¶ÒÔÉÏ¡£ Perinuclear space (ºËÖÜ϶)£ºÄÚºËĤºÍÍâºËĤ֮¼äµÄÇøÓò¡£ Periodicity of DNA (DNAµÄÖÜÆÚÂÊ)£ºÃ¿¸öË«ÂÝÐýתÍäÖÐËù°üº¬µÄ¼î»ù¶ÔÊý¡£ Permissive condition (Ðí¿ÉÌõ¼þ)£ºÔÊÐíÌõ¼þÖÂËÀÍ»±ä´æ»îµÄÌõ¼þ¡£ Peptite strains of yeast (½ÍĸС¾úÂäÖê)£ºÈ±ÉÙÏßÁ£Ì幦ÄܵĽÍĸͻ±äÖê¡£ Phage /bacteriophage(ÊɾúÌå/ϸ¾úÊɾúÌå)£ºÒ»ÖÖϸ¾ú²¡¶¾¡£ Phase variation (Ïàת±ä)£ºÖ¸Ï¸¾ú±ÞëÀàÐ͵ĸı䡣 Phenotype (±íÐÍ)£ºÒ»¸öÉúÎïµÄ±íÏÖ»òÆäËüÌØµã£¬ÊÇÒÅ´«ºÍ»·¾³Ï໥×÷ÓõÄ×îÖÕ±íÏÖ¡£ Phosphatase (Á×Ëáø)£ºÒ»ÖÖ´Óµ×ÎïÉÏÒÆ¿ªÁ×Ëá»ùÍŵÄø¡£ Plasma membrane (ÖÊĤ)£ºÏÞ¶¨Ã¿¸öϸ°û½çÏÞµÄÁ¬ÐøÄ¤Ìå¡£ Plasmid (ÖÊÁ£)£ºÈ¾É«ÌåÍâ×ÔÖ÷¸´ÖƵĻ·ÐÎDNA¡£ Playback experiment (ÔÙÏÖÊÔÑé)£ºÖØÐ»ñµÃÓëRNAÔÓ½»µÄDNA£¬´Ó¶øÍ¨¹ý¿ìËÙ¸´ÐÔ·´Ó¦¼ì ²éÆäÊÇ·ÇÖØ¸´ÐòÁС£ Plectonemic winding (Ïà²øÂÝÐý)£ºÖ¸µäÐ͵ÄË«ÂÝÐýDNA ÖÐÁ½ÌõÁ´µÄÏ໥²øÈÆ¡£ Pleiotropic gene (¶àЧ»ùÒò)£ºÓ°Ïì±íÐÍÉϲ»Ö¹Ò»¸öÌØµã(ÊDz»Ïà¹ØµÄ)µÄ»ùÒò¡£ Ploidy(±¶Êý)£ºÖ¸Ò»¸öϸ°ûÖгöÏÖµÄȾɫÌ忽±´Êý£¬µ¥±¶ÌåÖ»ÓÐÒ»¸ö¿½±´£¬¶þ±¶ÌåÓÐÁ½¸ö¿½ ±´£¬µÈµÈ¡£ Point mutation (µãÍ»±ä)£ºDNA Éϵ¥¸ö¼î»ù¶ÔµÄ¸Ä±ä¡£ Polarity (¼«ÐÔ)£ºÖ¸Ò»¸ö»ùÒòÍ»±äÓ°Ïìͬһת¼µ¥Î»ÏÂÓλùÒòµÄ±í´ï(ת¼»òÕß·Òë)µÄЧ¹û¡£ Polyadenylation (¶à¾ÛÏÙÜÕËữ)£ºÕæºËRNAת¼ʱ£¬ÏòÆä3¡é¶Ë¼ÓÈëһϵÁоÛÏÙÜÕËáµÄ¹ý³Ì¡£ Polycistronic mRNA (¶à˳·´×ÓmRNA)£º°üÀ¨²»Ö¹Ò»¸ö»ùÒò±àÂëÇøÓòµÄmRNA¡£ Polymorphism (¶à̬ÐÔ)£ºÖ¸»ùÒò×éȺÖÐͬʱ·¢ÉúµÄµÈλ»ùÒò²»Í¬(²»Í¬±íÐ͵ĵÈλ»ùÒò»òÏÞ ÖÆÐÔģʽµÄDNA ±ä»¯)¡£ Polyploid (¶à±¶Ìå)£ºÓÐÁ½Ì×ÒÔÉϵ¥±¶Ìå»ùÒò×é¡£ Polyrotein (¶à¾Ûµ°°×ÖÊ)£ºÄܼôÇгɼ¸¸ö¶ÀÁ¢µ°°×ÖʵĻùÒò²úÎï¡£ Polysome/polyribosome(¶à¾ÛºËÌÇÌå)£ºÊÇÒ»ÌõmRNA ÉϽáºÏ¶à¸ö²Î¼Ó·ÒëµÄºËÌÇÌå¡£ Polytene chromosomes(¶àÏßȾɫÌå)£ºÓÉÒ»ÌõȾɫÌå¶à´Î¸´ÖƵ«²»·ÖÀë²úÉú¡£ Position effect (λÖÃЧӦ)£ºÖ¸×ªÒƵ½»ùÒò×éÉÏÐÂλÖöøÒýÆð»ùÒò±í´ïµÄ¸Ä±ä£¬Èç»îÐÔ»ùÒò ÖÃÓÚÒìȾɫÖʸ½½ü»áʧ»î¡£ Position effect variegation (λÖÃЧӦ°ß²µ)£ºÖ¸Ò»¸ö»ùÒòÔÚijЩϸ°ûÖÐʧ»î¶øÔÚÆäËüϸ°ûÖÐ ÓлîÐÔ£¬ÊÇÒìȾɫÖÊ·Ç»îÐÔÇøÓòÑÓÉìµÄ½á¹û¡£ Positive regulator protein (Õýµ÷¿Øµ°°×)£ºÒ»¸öת¼µ¥Î»¼¤»îËù±ØÐëµÄµ°°×ÖÊ¡£ Positive supercoiling (Õý³¬ÂÝÐý)£ºË«Á´ÒÔÁ½ÌõÁ´²øÈƵķ½ÏòÐγɵij¬ÂÝÐý¡£ Postmeiotic segregation (¼õÊý·ÖÁѺó·ÖÀë)£ºµ±¸´ÖƺóÔÊÐíÁ½ÌõÁ´·Ö¿ªÊ±£¬º¬Óв»Í¬ÐÅÏ¢µÄ ÒìÔ´Ë«Á´DNA Á½ÌõÁ´·ÖÀëÏÖÏó¡£ Primary cells (Ôʼϸ°û)£ºÖ±½Ó´Ó¶¯ÎïÖÐÈ¡³ö·ÅÈëÅàÑø»ùÖеÄÕæºËϸ°û¡£ Primary transcript (³õ¼¶×ªÂ¼±¾)£ºÓëÒ»¸öת¼µ¥Î»Ïà¶ÔÓ¦µÄδÐÞÊÎRNA ²úÎï¡£ Primer (ÒýÎï)£ºÓëÒ»ÌõDNAÁ´Åä¶ÔµÄ¶ÌÐòÁÐ(ͨ³£ÊÇRNA)£¬Ìṩ×ÔÓÉ3¡éÄ©¶ËOH£¬Ê¹DNA ¾ÛºÏø¿ªÊ¼ºÏ³ÉDNA Á´¡£ Primosome (Òý·¢Ìå)£ºÖ¸ÔÚ·ÇÁ¬ÐøDNA¸´ÖÆÖУ¬Ã¿¸ö¸ÚÆéƬ¶ÎºÏ³ÉÒý·¢·´Ó¦ÖÐÉæ¼°µÄµ°°× Öʸ´ºÏÌå¡£Òý·¢ÌåÄÜÑØ×ÅDNA ÒÆ¶¯£¬²ÎÓëÁ¬ÐøµÄÒý·¢ ·´Ó¦¡£ Prion (È¶¾)£ºÒ»ÖÖµ°°×ÖʸÐȾ¿ÅÁ££¬¾¡¹ÜËü²»º¬ÓкËËᵫÊÇ¿ÉÒÅ´«µÄ¡£ÀýÈçÑòɧÑ÷²¡ºÍ Å£º£Ãà×´ÄÔ²¡Òò×ÓPrPscºÍÔÚ½ÍĸÖб£³ÖÒÅ´«×´Ì¬ µÄPsi¡£ Procentriole (ÔÖÐÐÄÁ£)£ºÎ´³ÉÊìµÄÖÐÐÄÁ££¬ÔÚ³ÉÊìÖÐÐÄÁ£¸½½üÐγɡ£ Processed pseudogene (ÒѼӹ¤¼Ù»ùÒò)£ºÈ±ÉÙÄÚº¬×ӵķǻîÐÔ»ùÒò¿½±´£¬Óë»îÐÔ»ùÒòµÄ¸îÁÑ ½á¹¹Ïà·´¡£¿ÉÄÜÆðÔ´ÓÚmRNA Äæ×ªÂ¼ÎïºÍË«¿½±´²å Èë»ùÒò×é¡£ Processive enzyme (½øÐÐÐÔø)£ºÁ¬Ðø×÷ÓÃÓÚÌØÊâµ×ÎïµÄø£¬ÔÚÖØ¸´µÄ´ß»¯¹ý³ÌÖв»·ÖÀë¡£ |
» ²ÂÄãϲ»¶
pull down RNAÖÊÁ¿ÓëĦ¶ûÖ®¼äµÄ»»Ëã
ÒѾÓÐ1È˻ظ´
ÔÚÔÑÐÒ©×ö¹ýÁ¿¹à×°£¬·ÂÖÆÒ©ÔÚʲôÇé¿öÏ¿ÉÒÔ²»×ö¹ýÁ¿¹à×°£¿
ÒѾÓÐ0È˻ظ´
ÖÐҩѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ59È˻ظ´
¹ýÁ¿¹à×°
ÒѾÓÐ2È˻ظ´
ÈçºÎ°´µ¥Î»²éѯ2021Äê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿£¿
ÒѾÓÐ3È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
1
|
2Â¥2006-05-17 07:57:44
huangrong
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8314.3
- Ìû×Ó: 396
- ÔÚÏß: 47.2Сʱ
- ³æºÅ: 166079
- ×¢²á: 2006-01-13
- ÐÔ±ð: MM
- רҵ: ºôÎüϵͳ¼²²¡ÕïÁÆÐ¼¼Êõ
3Â¥2006-05-17 11:57:17














»Ø¸´´ËÂ¥